Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci

被引：29
|
作者：
Coque, TM
Singh, KV
Murray, BE
机构：
[1] UNIV TEXAS,SCH MED,DIV INFECT DIS,DEPT INTERNAL MED,HOUSTON,TX 77030
[2] UNIV TEXAS,SCH MED,DEPT MICROBIOL & MOLEC GENET,HOUSTON,TX 77030
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1996年 / 37卷 / 05期
关键词：
D O I：
10.1093/jac/37.5.1011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The in-vitro activities of the new fluoroquinolone trovafloxacin (CP-99,219) and ciprofloxacin were determined against 225 Gram-positive cocci. Trovafloxacin was 4-32 fold more active than ciprofloxacin against staphylococci and streptococci and also showed greater activity against enterococci including vancomycin resistant Enterococcus faecium and Enterococcus faecalis that were highly resistant to aminoglycosides and/or produced beta-lactamase. Trovafloxacin was also bactericidal at 3 mg/L against enterococci except for isolates for which the MICs were greater than or equal to 2 mg/L.
引用
收藏
页码：1011 / 1016
页数：6
相关论文
共 50 条
  • [41] In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates
    Felmingham, D
    Robbins, MJ
    Ingley, K
    Mathias, I
    Bhogal, H
    Leakey, A
    Ridgway, GL
    Gruneberg, RN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 43 - 49
  • [42] COMPARATIVE INVITRO ACTIVITY OF PD-127391, A NEW FLUOROQUINOLONE AGENT, AGAINST SUSCEPTIBLE AND RESISTANT CLINICAL ISOLATES OF GRAM-POSITIVE COCCI
    MIRANDA, AG
    WANGER, AR
    SINGH, KV
    MURRAY, BE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) : 1325 - 1328
  • [43] Bactericidal activity of citrate against Gram-positive cocci
    Lee, YL
    Thrupp, L
    Owens, J
    Cesario, T
    Shanbrom, E
    LETTERS IN APPLIED MICROBIOLOGY, 2001, 33 (05) : 349 - 351
  • [44] INVITRO ACTIVITY OF KITASAMYCIN AGAINST GRAM-POSITIVE COCCI
    BALDUCCI, Y
    BODEY, GP
    JOURNAL OF ANTIBIOTICS, 1974, 27 (07): : 516 - 519
  • [45] Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against Gram-positive cocci of known erythromycin susceptibility status
    Hamilton-Miller, JMT
    Shah, S
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 649 - 653
  • [46] INVITRO ACTIVITY OF CIPROFLOXACIN AGAINST GRAM-POSITIVE COCCI
    BARRY, AL
    JONES, RN
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 27 - 32
  • [47] In vitro activity of tigecycline against Gram-positive cocci:: a multicentre study in Greece
    Malli, E.
    Spiliopoulou, I.
    Kolonitsiou, F.
    Neocleous, Ch.
    Klapsa, D.
    Pantelidi, K.
    Panopoulou, M.
    Grapsa, S.
    Alepopoulou, E.
    Neonakis, I.
    Alexiou-Daniel, S.
    Bakola, D.
    Koutsia-Carouzou, C.
    Malamou-Lada, H.
    Zerva, L.
    Vlahaki, E.
    Kartali-Ktenidou, S.
    Anastassiou, E.
    Petinaki, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1158 - 1160
  • [48] In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci
    Hope, Russell
    Chaudhry, Aiysha
    Adkin, Rachael
    Livermore, David M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (03) : 213 - 217
  • [49] Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci
    Ravaoarinoro, M
    Therrien, C
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 7 (03) : 167 - 170
  • [50] Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms
    Blondeau, JM
    Laskowski, R
    Bjarnason, J
    Stewart, C
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (01) : 45 - 50
12345